Carmignac Gestion’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Carmignac Gestion’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-70,439	Closed	-$3.27M	–	176
2023 Q2	$3.27M	Buy	+70,439	New	+$2.43M	0.06%	86

Carmignac Gestion's DICE Position: Q3 2023 in Review

Carmignac Gestion sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 70,439 shares — an estimated $3.27M sold.

Carmignac Gestion first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $3.27M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Carmignac Gestion reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Carmignac Gestion sold 70,439 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.27M.
Carmignac Gestion first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Carmignac Gestion's DICE Therapeutics, Inc. Common Stock position peaked at $3.27M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Carmignac Gestion's 13F filing for Q3 2023, filed 13 Nov 2023.